Organogenesis Holdings Inc. (ORGO) › Shareholders' EquityOrganogenesis Holdings Inc. (ORGO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: $3.51M2016: -$15.98M2017: -$15.32M2018: $39.94M2019: $52.02M2020: $141.81M2021: $241.34M2022: $265.67M2023: $278.66M2024: $262.90M2025: $300.13M$300.13M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$300.13M+14.2%2024$262.90M-5.7%2023$278.66M+4.9%2022$265.67M+10.1%2021$241.34M+70.2%2020$141.81M+172.6%2019$52.02M+30.3%2018$39.94M+360.7%2017-$15.32M+4.1%2016-$15.98M-554.7%2015$3.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share